Claroty, a New York-based industrial cybersecurity firm, announced that it raised $400 million in Series E funding and agreed to acquire Medigate, a leading healthcare IoT security firm, as part of its mission to secure all cyber-physical systems (CPS) across industrial, healthcare, and enterprise environments the Extended Internet of Things (XIoT). The round brings the company’s total funding to $635 million.
The Series E funding was co-led by new investor SoftBank Vision Fund 2, as well as existing investors Bessemer Venture Partners and Schneider Electric. Other existing investors, including ISTARI (a global cybersecurity platform established by Temasek), Team8, and Standard Investments, participated as well.
Additionally, Yossi Cohen, head of SoftBank’s investment activities in Israel, will join Claroty’s board of directors.
Company: Claroty Inc
Round: Series E
Funding Month: December 2021
Lead Investors: SoftBank Vision Fund 2, Bessemer Venture Partners, and Schneider Electric
Additional Investors: ISTARI, Team8, and Standard Investments
Company Website: https://www.claroty.com/
Software Category: Industrial cybersecurity
About the Company: Claroty empowers organizations to secure cyber-physical systems across industrial (OT), healthcare (IoMT), and enterprise (IoT) environments: the Extended Internet of Things (XIoT). The company’s unified platform integrates with customers’ existing infrastructure to provide a full range of controls for visibility, risk and vulnerability management, threat detection, and secure remote access. Backed by the world’s largest investment firms and industrial automation vendors, Claroty is deployed by hundreds of organizations at thousands of sites globally. The company is headquartered in New York City and has a presence in Europe, Asia-Pacific, and Latin America.